Bioinformatic analysis showed that inflammatory pathways such as TLR-MyD88, NF-κB and MAPK pathways were activated in both IC/BPS patients and EAC mice, which was validated by in vitro cell experiments. This evidence concerns the gene NFKB1 and Bartsocas-Papas syndrome 1.